Insights

What the DOL’s Final PBM Fee Disclosure Rule Means for Self-Funded Plans, TPAs and Brokers 

Learn More

GLP-1 Coverage in 2027 Brings New Prices, New Options and Tougher Decisions

Learn More

What’s Happening in Pharmacy Right Now—What You Need to Know Before Your 2027 Renewals

Learn More

The Multimillion-Dollar Question Behind Cell and Gene Therapies for Plan Sponsors 

Learn More

Rebate Credits: The Contract Loophole Costing Employers Real Money

Learn More

GLP-1s Are Changing the Math for Plan Sponsors: How Market Shifts Are Reshaping Rx Decisions 

Learn More

Q3 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Insights

What the DOL’s Final PBM Fee Disclosure Rule Means for Self-Funded Plans, TPAs and Brokers 

OnPoint-Light-Dark 2

A Navion Video Series

Welcome to On Point with Navion. In five minutes or less, we’ll break down what’s happening in pharmacy, what it means for your groups, and what to do next. No fluff, just what you need to know every month.

GET STARTED

Experience Navion in action with a savings analysis!

Our custom Rx savings analysis delivers a side by-side assessment to ensure your groups have a single source of truth to choose the PBM option that’s right for them.